AU2013257516A1 - (Z)-2-Cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability - Google Patents

(Z)-2-Cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Info

Publication number: AU2013257516A1
Authority: AU; Australia
Prior art keywords: trifluormethylphenyl; cyano; hydroxy; enoic acid; improved stability
Prior art date: 2009-09-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2013257516A

Other versions

AU2013257516B2 (en

Inventor

Gerrit Hauck

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis Deutschland GmbH

Original Assignee

Sanofi Aventis Deutschland GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-09-18

Filing date

2013-11-18

Publication date

2013-12-05

2010-09-14 Priority claimed from AU2010297357A external-priority patent/AU2010297357B2/en

2013-11-18 Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH

2013-11-18 Priority to AU2013257516A priority Critical patent/AU2013257516B2/en

2013-12-05 Publication of AU2013257516A1 publication Critical patent/AU2013257516A1/en

2015-09-17 Application granted granted Critical

2015-09-17 Publication of AU2013257516B2 publication Critical patent/AU2013257516B2/en

2021-04-08 Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH Request for Assignment Assignors: SANOFI

Status Active legal-status Critical Current

2030-09-14 Anticipated expiration legal-status Critical

Links

AU2013257516A 2009-09-18 2013-11-18 (Z)-2-Cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability Active AU2013257516B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2013257516A AU2013257516B2 (en)	2009-09-18	2013-11-18	(Z)-2-Cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
EP09290716.1		2009-09-18
EP09290716		2009-09-18
US61/363,382		2010-07-12
AU2010297357A AU2010297357B2 (en)	2009-09-18	2010-09-14	(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
AU2013257516A AU2013257516B2 (en)	2009-09-18	2013-11-18	(Z)-2-Cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2010297357A Division AU2010297357B2 (en)	2009-09-18	2010-09-14	(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Publications (2)

Publication Number	Publication Date
AU2013257516A1 true AU2013257516A1 (en)	2013-12-05
AU2013257516B2 AU2013257516B2 (en)	2015-09-17

Family

ID=41510564

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2010297357A Active AU2010297357B2 (en)	2009-09-18	2010-09-14	(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
AU2013257516A Active AU2013257516B2 (en)	2009-09-18	2013-11-18	(Z)-2-Cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2010297357A Active AU2010297357B2 (en)	2009-09-18	2010-09-14	(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

Country Status (41)

Country	Link
US (5)	US20120172427A1 (en)
EP (1)	EP2477611B1 (en)
JP (1)	JP2013505213A (en)
KR (1)	KR101547880B1 (en)
CN (4)	CN104666272A (en)
AR (1)	AR078383A1 (en)
AU (2)	AU2010297357B2 (en)
BR (1)	BR112012006184B1 (en)
CA (1)	CA2772275A1 (en)
CL (1)	CL2015000047A1 (en)
CO (1)	CO6511244A2 (en)
CR (2)	CR20170078A (en)
CY (1)	CY1119364T1 (en)
DK (1)	DK2477611T3 (en)
DO (1)	DOP2012000070A (en)
ES (1)	ES2625731T3 (en)
GT (1)	GT201200075A (en)
HK (1)	HK1206244A1 (en)
HN (1)	HN2012000576A (en)
HR (1)	HRP20170904T1 (en)
HU (1)	HUE032963T2 (en)
IL (3)	IL218492A (en)
JO (1)	JO3327B1 (en)
LT (1)	LT2477611T (en)
MA (1)	MA33585B1 (en)
ME (1)	ME02765B (en)
MX (1)	MX336663B (en)
MY (1)	MY155613A (en)
NZ (2)	NZ617025A (en)
PE (2)	PE20121478A1 (en)
PL (1)	PL2477611T3 (en)
PT (1)	PT2477611T (en)
RS (1)	RS56074B1 (en)
RU (2)	RU2012115459A (en)
SI (1)	SI2477611T1 (en)
SM (1)	SMT201700299T1 (en)
TN (1)	TN2012000061A1 (en)
TW (2)	TWI468190B (en)
UA (2)	UA107582C2 (en)
UY (1)	UY32889A (en)
WO (1)	WO2011032929A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2477611T3 (en) *	2009-09-18	2017-09-29	Sanofi	(z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
RU2493845C1 (en) *	2012-06-07	2013-09-27	Общество с ограниченной ответственностью "ВАЛЕНТА ИНТЕЛЛЕКТ"	Composition for treating multiple sclerosis (versions)
WO2015077535A2 (en) *	2013-11-22	2015-05-28	Genzyme Corporation	Novel methods for treating neurodegenerative diseases
CN103656657A (en) *	2013-12-18	2014-03-26	北京科源创欣科技有限公司	Teriflunomide drug composition and preparation method
ES3014202T3 (en)	2014-03-26	2025-04-21	Astex Therapeutics Ltd	Cmet-inhibitors for use in delaying the emergence in resistance to fgfr inhibitors
US20160058730A1 (en) *	2014-08-29	2016-03-03	Cadila Healthcare Limited	Pharmaceutical compositions of teriflunomide
WO2016079687A1 (en) *	2014-11-18	2016-05-26	Lupin Limited	Oral pharmaceutical composition of teriflunomide
JOP20200201A1 (en)	2015-02-10	2017-06-16	Astex Therapeutics Ltd	Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine
US20180147148A1 (en)	2015-05-23	2018-05-31	Ftf Pharma Private Limited	Pharmaceutical composition of teriflunomide
WO2017037022A1 (en)	2015-09-01	2017-03-09	Bayer Pharma Aktiengesellschaft	Compounds and methods useful for treating or preventing hematological cancers
WO2017037645A1 (en) *	2015-09-02	2017-03-09	Leiutis Pharmaceuticals Pvt Ltd	Stable pharmaceutical formulations of teriflunomide
WO2017056104A1 (en) *	2015-09-28	2017-04-06	Natco Pharma Limited	Stable pharmaceutical compositions of teriflunomide
WO2017125841A1 (en) *	2016-01-20	2017-07-27	Emcure Pharmaceuticals Limited	Pharmaceutical compositions of teriflunomide
JOP20190207A1 (en) *	2017-03-14	2019-09-10	Actelion Pharmaceuticals Ltd	Pharmaceutical combination comprising ponesimod
EP3999038B1 (en) *	2019-07-17	2024-01-10	Cytokinetics, Inc.	Cardiac sarcomere inhibitor oral formulations
RS66027B1 (en)	2020-07-07	2024-11-29	Celgene Corp	Pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)m ethyl) benzyl)piperazin-1-yl)-3-fluorobenzonitrile and methods of using the same
WO2022085015A1 (en) *	2020-10-24	2022-04-28	V-Ensure Pharma Technologies Private Limited	A solid oral composition of teriflunomide
GR1010137B (en)	2020-12-15	2021-12-07	Φαρματεν Α.Β.Ε.Ε.,	Immediate release solid dosage form comprising teriiflunomide and method of prepeartion thereof
TR202022336A2 (en) *	2020-12-30	2022-07-21	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	A FILM COATED TABLET COMPRISING TERIFLUNOOMIDE
EP4382097A1 (en)	2022-11-25	2024-06-12	Sanovel Ilac Sanayi Ve Ticaret A.S.	A tablet comprising teriflunomide
WO2024112298A1 (en) *	2022-11-25	2024-05-30	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	A tablet comprising teriflunomide

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3852294A (en) *	1968-08-27	1974-12-03	Merck Patent Gmbh	Bis-quaternary pyridinium salts
DE3534440A1 (en)	1985-09-27	1987-04-02	Hoechst Ag	DRUGS AGAINST CHRONIC GRAFT VERSUS HOST DISEASES AND AUTO AUTO DISEASES, IN PARTICULAR SYSTEMIC LUPUS ERYTHEMATODES
US5268382A (en)	1985-09-27	1993-12-07	Hoechst Aktiengesellschaft	Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
US6133301A (en)	1991-08-22	2000-10-17	Aventis Pharma Deutschland Gmbh	Pharmaceuticals for the treatment of rejection reactions in organ transplantations
US5700823A (en)	1994-01-07	1997-12-23	Sugen, Inc.	Treatment of platelet derived growth factor related disorders such as cancers
GB9408117D0 (en) *	1994-04-23	1994-06-15	Smithkline Beecham Corp	Pharmaceutical formulations
KR100365064B1 (en)	1994-10-17	2003-04-11	훽스트파마슈티칼스앤드케미칼스가부시키가이샤	Prevention and treatment of type I allergic diseases
PT903345E (en)	1997-08-08	2001-01-31	Aventis Pharma Gmbh	CRYSTALLINE FORM OF N- (4-TRIFLUOROMETHYLPHENYL) -5-METHYL ISOXAZOLE-4-CARBOXAMIDE
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
HUP0301865A3 (en)	2000-02-15	2005-12-28	Teva Pharma	A method for synthesizing leflunomide
ES2305287T3 (en)	2001-04-05	2008-11-01	Aventis Pharmaceuticals Inc.	USE OF (4'-TRIFLUOROMETIFENIL) -AMIDE OF THE ACID (Z) -CIANO-3-HYDROXI-BUT-2-ENOIC TO TREAT MULTIPLE SCLEROSIS.
GB0123571D0 (en) *	2001-04-05	2001-11-21	Aventis Pharm Prod Inc	Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
US20050158371A1 (en)	2002-02-12	2005-07-21	Sumitomo Pharmaceuticals Co., Ltd.	Novel external agent
ATE495739T1 (en) *	2003-08-29	2011-02-15	Transform Pharmaceuticals Inc	PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING LEVODOPA AND CARBIDOPA
GB2394660A (en)	2003-12-17	2004-05-05	Niche Generics Ltd	Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
US20050220874A1 (en) *	2004-04-02	2005-10-06	Chien-Hsuan Han	Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
US20060024376A1 (en) *	2004-07-30	2006-02-02	The University Of Chicago	Methods and compositions for reducing toxicity associated with leflunomide treatment
CA2584655A1 (en) *	2004-10-19	2006-04-27	Aventis Pharmaceuticals Inc.	Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease
TWI275029B (en) *	2005-11-18	2007-03-01	Hon Hai Prec Ind Co Ltd	An embedded system and method for processing data thereof
JP2009524658A (en)	2006-01-24	2009-07-02	テバファーマシューティカルインダストリーズリミティド	Levetiracetam preparation and method for producing the same
DE102006017896A1 (en)	2006-04-13	2007-10-25	Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg	Leflunomide-containing pharmaceutical compositions
EP1990048A3 (en)	2007-05-08	2009-05-06	Ulrike Wiebelitz	Therapy of benign prostatic hyperplasia (bph)
PL2477611T3 (en) *	2009-09-18	2017-09-29	Sanofi	(z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
EP2762135A1 (en) *	2013-02-04	2014-08-06	Sanofi	Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients

2010
- 2010-09-14 PL PL10752585T patent/PL2477611T3/en unknown
- 2010-09-14 UA UAA201204827A patent/UA107582C2/en unknown
- 2010-09-14 SI SI201031476A patent/SI2477611T1/en unknown
- 2010-09-14 MX MX2012003122A patent/MX336663B/en unknown
- 2010-09-14 UA UAA201409985A patent/UA115979C2/en unknown
- 2010-09-14 AU AU2010297357A patent/AU2010297357B2/en active Active
- 2010-09-14 HR HRP20170904TT patent/HRP20170904T1/en unknown
- 2010-09-14 HU HUE10752585A patent/HUE032963T2/en unknown
- 2010-09-14 MY MYPI2012000646A patent/MY155613A/en unknown
- 2010-09-14 DK DK10752585.9T patent/DK2477611T3/en active
- 2010-09-14 RU RU2012115459/15A patent/RU2012115459A/en unknown
- 2010-09-14 PE PE2012000342A patent/PE20121478A1/en not_active Application Discontinuation
- 2010-09-14 BR BR112012006184-4A patent/BR112012006184B1/en active IP Right Grant
- 2010-09-14 CN CN201510052347.5A patent/CN104666272A/en active Pending
- 2010-09-14 WO PCT/EP2010/063439 patent/WO2011032929A1/en not_active Ceased
- 2010-09-14 NZ NZ617025A patent/NZ617025A/en unknown
- 2010-09-14 CR CR20170078A patent/CR20170078A/en unknown
- 2010-09-14 ES ES10752585.9T patent/ES2625731T3/en active Active
- 2010-09-14 KR KR1020127006940A patent/KR101547880B1/en active Active
- 2010-09-14 CN CN201510052299.XA patent/CN104739821B/en not_active Ceased
- 2010-09-14 RU RU2015151938A patent/RU2681079C2/en active
- 2010-09-14 SM SM20170299T patent/SMT201700299T1/en unknown
- 2010-09-14 ME MEP-2017-134A patent/ME02765B/en unknown
- 2010-09-14 CN CN201080041529.8A patent/CN102596184B/en active Active
- 2010-09-14 CN CN201510052300.9A patent/CN104666238B/en not_active Ceased
- 2010-09-14 EP EP10752585.9A patent/EP2477611B1/en not_active Revoked
- 2010-09-14 CA CA2772275A patent/CA2772275A1/en not_active Abandoned
- 2010-09-14 PT PT107525859T patent/PT2477611T/en unknown
- 2010-09-14 US US13/395,586 patent/US20120172427A1/en not_active Abandoned
- 2010-09-14 NZ NZ598744A patent/NZ598744A/en unknown
- 2010-09-14 JP JP2012529234A patent/JP2013505213A/en not_active Abandoned
- 2010-09-14 LT LTEP10752585.9T patent/LT2477611T/en unknown
- 2010-09-14 RS RS20170589A patent/RS56074B1/en unknown
- 2010-09-14 PE PE2015002059A patent/PE20152031A1/en active IP Right Grant
- 2010-09-16 TW TW99131364A patent/TWI468190B/en active
- 2010-09-16 JO JOP/2010/0317A patent/JO3327B1/en active
- 2010-09-16 UY UY0001032889A patent/UY32889A/en not_active Application Discontinuation
- 2010-09-16 AR ARP100103381A patent/AR078383A1/en not_active Application Discontinuation
- 2010-09-16 TW TW103142089A patent/TWI522130B/en active
2012
- 2012-02-10 TN TNP2012000061A patent/TN2012000061A1/en unknown
- 2012-03-05 IL IL218492A patent/IL218492A/en active IP Right Grant
- 2012-03-12 CR CR20120116A patent/CR20120116A/en unknown
- 2012-03-13 MA MA34687A patent/MA33585B1/en unknown
- 2012-03-15 CO CO12045392A patent/CO6511244A2/en active IP Right Grant
- 2012-03-16 DO DO2012000070A patent/DOP2012000070A/en unknown
- 2012-03-16 US US13/422,494 patent/US8802735B2/en active Active
- 2012-03-16 GT GT201200075A patent/GT201200075A/en unknown
- 2012-03-16 HN HN2012000576A patent/HN2012000576A/en unknown
2013
- 2013-11-18 AU AU2013257516A patent/AU2013257516B2/en active Active
2014
- 2014-04-30 US US14/265,433 patent/US20140235888A1/en not_active Abandoned
2015
- 2015-01-08 CL CL2015000047A patent/CL2015000047A1/en unknown
- 2015-07-16 HK HK15106785.9A patent/HK1206244A1/en unknown
2016
- 2016-03-28 IL IL244809A patent/IL244809B/en active IP Right Grant
- 2016-10-11 US US15/290,677 patent/US20170247319A1/en not_active Abandoned
2017
- 2017-07-04 CY CY20171100710T patent/CY1119364T1/en unknown
2018
- 2018-08-20 US US15/999,565 patent/US20190241505A1/en not_active Abandoned
2019
- 2019-02-19 IL IL26491219A patent/IL264912B/en active IP Right Grant

Publication	Publication Date	Title
IL264912B (en)	2019-11-28	(z)-2-cyano-3-hydroxy-but-2-enoic acid-(4’-trifluormethylphenyl)-amide tablet formulations with improved stability
AU2013257516A1 (en)	2013-12-05	(Z)-2-Cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
HUS1800043I1 (en)	2018-11-28	Pharmaceutical formulation 514
IL201891A0 (en)	2010-06-16	Novel pharmaceutical composition
ZA201001303B (en)	2015-12-23	Non-aqueous pharmaceutical compositions
GB0720716D0 (en)	2007-12-05	Novel formulation
GB0806978D0 (en)	2008-05-21	Novel formulations
ZA201006766B (en)	2011-05-25	Pharmaceutical composition 271
ZA201007197B (en)	2011-06-29	Raloxifene pharmaceutical formulations
EP2236135A4 (en)	2012-05-02	Stable pharmaceutical composition
GB0701368D0 (en)	2007-03-07	Novel pharmaceutical compositions
GB0701364D0 (en)	2007-03-07	Novel pharmaceutical compositions
GB0701367D0 (en)	2007-03-07	Novel pharmaceutical compositions
GB0713794D0 (en)	2007-08-22	Novel pharmaceutical compositions
GB0704749D0 (en)	2007-04-18	Novel pharmaceutical compositions
GB0720719D0 (en)	2007-12-05	Novel formulation
GB0805807D0 (en)	2008-04-30	Novel pharmaceutical compositions
GB0804485D0 (en)	2008-04-16	Novel pharmaceutical compositions
AU2009904104A0 (en)	2009-09-17	March 24
AU2009200375A1 (en)	2010-08-19	Aquamiser "Aquapad"
GB0718318D0 (en)	2007-10-31	Non-aqueous pharmaceutical compositions
GB0813121D0 (en)	2008-08-27	Novel formulations
HK1169403A (en)	2013-01-25	2-carboxamide-7-piperazinyl-benzofuran derivatives 774
AP2007004090A0 (en)	2007-08-31	Novel pharmaceutical composition
AU2010902506A0 (en)	2010-06-24	Synaptai'd